BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.32
+6.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 6.42x
- P/E 2028E
- 6.76x
- P/S forward
- 0.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.29x
- Price / sales
- 0.42x
- Price / cash flow
- -2.47x
Enterprise value
- Enterprise value
- $22.4M
- EV / sales
- 0.49x
- EV / EBITDA
- -3.99x
- EV / EBIT
- -5.14x
- Market cap
- $19.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026